Cargando…
Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer
SIMPLE SUMMARY: In patients with completely resected stage III pN2 non-small cell lung cancer (NSCLC), adjuvant chemotherapy of 4–6 cycles was recommended prior to post-operative radiotherapy (PORT). However, some were given concurrently or early-sequentially with PORT. The objectives of this study...
Autores principales: | Lin, Shih-Min, Ku, Hsiu-Ying, Hsu, Che-Yu, Wang, Chih-Liang, Chang, Gee-Chen, Chang, Cheng-Shyong, Liu, Tsang-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160867/ https://www.ncbi.nlm.nih.gov/pubmed/34065341 http://dx.doi.org/10.3390/cancers13102494 |
Ejemplares similares
-
The Impact of Prolonged Chemotherapy to Surgery Interval and
Neoadjuvant Radiotherapy on Pathological Complete Response and Overall Survival
in Pancreatic Cancer Patients
por: Azab, Basem, et al.
Publicado: (2020) -
Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer
por: Wang, Bing-Yen, et al.
Publicado: (2016) -
Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy
por: Chen, Shin-Cheh, et al.
Publicado: (2021) -
An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2016) -
Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy
por: Chou, Hsu-Huan, et al.
Publicado: (2019)